Use of Integrated Pulmonary Index Monitorisation in Children Undergoing Botulinum Toxin Injection

NCT05724030 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2024-10-15

No results posted yet for this study

Summary

This study aimed to detect hypoxia early with ıntegrated pulmonary index monitoring compared to saturation.

Conditions

  • Cerebral Palsy
  • Pediatric ALL

Interventions

DEVICE

integrated pulmonary index

integarted pumobary index monitoring

DEVICE

saturation

saturation monitorization

Sponsors & Collaborators

  • Kocaeli University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
4 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-03
Primary Completion
2024-09-03
Completion
2024-10-11

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05724030 on ClinicalTrials.gov